Literature DB >> 19331753

Mycobacterium colombiense and pseudotuberculous lymphadenopathy.

Katariina Vuorenmaa, Iskandar Ben Salah, Vincent Barlogis, Hervé Chambost, Michel Drancourt.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19331753      PMCID: PMC2671429          DOI: 10.3201/eid1504.081436

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Mycobacterium colombiense is a new species belonging to the M. avium complex (MAC). It is characterized by a unique internal transcribed spacer sequence and causing respiratory tract and disseminated infection in HIV-infected patients in Colombia (). We report clinical and histologic features of lymphadenopathy resulting from M. colombiense infection. A 25-month-old girl with an unremarkable medical history was hospitalized in the pediatric department of Timone Hospital, Marseille, France, due to development of swelling in a right subclavicular lymph node over a 1-month period. A 5-day course of oxacillin, which was administered orally, had been unsuccessful in alleviating the symptoms. The patient’s general condition was excellent, and results of a physical examination were normal, with the exception of a 2-cm hard, immobile, yet painless, noninflammatory, enlarged lymph node. Due to the presence of the enlarged lymph node, a chest radiograph was performed, and results were normal. A hemogram indicated a hemoglobin concentration of 113 g/L, a leukocyte count 8.3 × 109/L consisting of 31% polynuclear neutrophils and 62% lymphocytes, and a normal blood smear. A platelet count indicated a concentration of 389 × 109/L, and the serum lactic dehydrogenase level was 440 UI/L. In addition, no biologic inflammatory syndrome was observed based on the concentration of C-reactive protein (<1 mg/L) and an erythrocyte sedimentation rate of 18 mm/h. Fine-needle aspiration of the lymph node showed necrosis and mature, activated lymphocytes. These results suggested a possible diagnosis of lymphoma, and a surgical excision biopsy was subsequently performed. Direct microscopic examinations were carried out after results obtained by Gram and Ziehl-Neelsen staining showed that the lymph node was negative for acid-fast bacilli. Histopathologic analysis indicated epithelioid cell granulomas containing giant cells and caseous necrosis without altered leukocytes, all of which are compatible with tuberculosis. Culturing of the biopsy specimen in BACTEC broth (Becton Dickinson, Courtaboeuf, France) at 5% CO2 at 37°C yielded acid-fast bacilli after a 7-day incubation period. After inactivating the cells and extracting the DNA by using a previously described method, we identified the isolate by PCR sequencing of the rpoB gene () and its demonstrated 100% sequence similarity to M. colombiense CIP108962T (,). Accordingly, the isolate exhibited positive urease activity, a distinctive characteristic that differentiates M. colombiense from other MAC species (,). Recently, M. colombiense was shown to be responsible for an enlarged lymph node in 1 child from Spain who did not show any evidence of HIV infection (). In that patient, histopathologic examination showed granulomatous adenitis with necrosis. We report that M. colombiense–infected lymph nodes also yield clinical and histopathologic features evocative of tuberculosis. Indeed, MAC organisms remain the most prevalent agents demonstrated in diseased lymph nodes in children (). Because modern molecular tools used for the description of emerging MAC species have not been available in most previous reports, the real prevalence of M. colombiense may have been underestimated. In children, M. hemophilum (), M. avium subsp. avium (), M. avium subsp. hominissuis (), M. lentiflavum (), M. bohemicum (), and M. simiae () have been demonstrated to be responsible for enlarged cervical lymph nodes (Appendix Table). Because management and antimicrobial drug treatment of each of these different infections vary in terms of indication, choice of drugs, and duration, the accurate and rapid identification of the causative Mycobacterium species is absolutely necessary. This identification should use PCR sequencing of selected universal molecular targets, including the 16S rRNA and rpoB genes (), as illustrated herein.

Appendix Table

Mycobacterium spp. implicated in lymphadenopathy in children, France*
  10 in total

1.  Mycobacterium colombiense sp. nov., a novel member of the Mycobacterium avium complex and description of MAC-X as a new ITS genetic variant.

Authors:  Martha I Murcia; Enrico Tortoli; M Carmen Menendez; Elia Palenque; Maria J Garcia
Journal:  Int J Syst Evol Microbiol       Date:  2006-09       Impact factor: 2.747

2.  Management of nontuberculous mycobacteria-induced cervical lymphadenitis with observation alone.

Authors:  Avraham Zeharia; Tal Eidlitz-Markus; Yishai Haimi-Cohen; Zmira Samra; Lea Kaufman; Jacob Amir
Journal:  Pediatr Infect Dis J       Date:  2008-10       Impact factor: 2.129

3.  rpoB sequence-based identification of Mycobacterium avium complex species.

Authors:  Iskandar Ben Salah; Toidi Adékambi; Didier Raoult; Michel Drancourt
Journal:  Microbiology       Date:  2008-12       Impact factor: 2.777

4.  Lymphadenopathy caused by Mycobacterium colombiense.

Authors:  Oscar Esparcia; Ferran Navarro; Miquel Quer; Pere Coll
Journal:  J Clin Microbiol       Date:  2008-02-27       Impact factor: 5.948

Review 5.  Cervical lymphadenitis caused by Mycobacterium lentiflavum.

Authors:  Froilán Cabria; Maria-Viarce Torres; Jose-Ignacio García-Cía; Maria-Nieves Dominguez-Garrido; Jaime Esteban; Maria Soledad Jimenez
Journal:  Pediatr Infect Dis J       Date:  2002-06       Impact factor: 2.129

6.  Mycobacterium simiae cervical lymphadenitis.

Authors:  Niraj C Patel; Paul K Minifee; Megan K Dishop; Flor M Munoz
Journal:  Pediatr Infect Dis J       Date:  2007-04       Impact factor: 2.129

7.  Mycobacterium bohemicum and cervical lymphadenitis in children.

Authors:  Julia Huber; Elvira Richter; Lothar Binder; Matthias Maass; Robert Eberl; Werner Zenz
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

8.  Mycobacterium haemophilum and lymphadenitis in immunocompetent children, Israel.

Authors:  Yishai Haimi Cohen; Jacob Amir; Shai Ashkenazi; Tal Eidlitz-Markus; Zmira Samra; Lea Kaufmann; Avraham Zeharia
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

9.  Mycobacterium avium lymphadenopathy among children, Sweden.

Authors:  Johanna Thegerström; Victoria Romanus; Vanda Friman; Lars Brudin; Paul D Haemig; Björn Olsen
Journal:  Emerg Infect Dis       Date:  2008-04       Impact factor: 6.883

10.  Lymphadenitis in children is caused by Mycobacterium avium hominissuis and not related to 'bird tuberculosis'.

Authors:  L E S Bruijnesteijn van Coppenraet; P E W de Haas; J A Lindeboom; E J Kuijper; D van Soolingen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-05       Impact factor: 3.267

  10 in total
  13 in total

Review 1.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

2.  Genome sequence of the Mycobacterium colombiense type strain, CECT 3035.

Authors:  Mónica González-Pérez; Martha I Murcia; David Landsman; I King Jordan; Leonardo Mariño-Ramírez
Journal:  J Bacteriol       Date:  2011-10       Impact factor: 3.490

3.  Virulence and immune response induced by Mycobacterium avium complex strains in a model of progressive pulmonary tuberculosis and subcutaneous infection in BALB/c mice.

Authors:  Mónica González-Pérez; Leonardo Mariño-Ramírez; Carlos Alberto Parra-López; Martha Isabel Murcia; Brenda Marquina; Dulce Mata-Espinoza; Yadira Rodriguez-Míguez; Guillermina J Baay-Guzman; Sara Huerta-Yepez; Rogelio Hernandez-Pando
Journal:  Infect Immun       Date:  2013-08-19       Impact factor: 3.441

4.  Diversity of Mycobacterium avium subsp. hominissuis mycobacteria causing lymphadenitis, France.

Authors:  L Despierres; S Cohen-Bacrie; H Richet; M Drancourt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-25       Impact factor: 3.267

5.  Prevalence of non-tuberculous mycobacteria among previously treated TB patients in the Gulf of Guinea, Africa.

Authors:  B D Thumamo Pokam; D Yeboah-Manu; S Ofori; P W Guemdjom; P M Teyim; L Lawson; D Amiteye; N Y Yhiler; I C Djuikoue; A E Asuquo
Journal:  IJID Reg       Date:  2022-05-14

6.  Surviving within the amoebal exocyst: the Mycobacterium avium complex paradigm.

Authors:  Iskandar Ben Salah; Michel Drancourt
Journal:  BMC Microbiol       Date:  2010-04-01       Impact factor: 3.605

7.  Sliding Motility, Biofilm Formation, and Glycopeptidolipid Production in Mycobacterium colombiense Strains.

Authors:  Milena Maya-Hoyos; John Leguizamón; Leonardo Mariño-Ramírez; Carlos Y Soto
Journal:  Biomed Res Int       Date:  2015-05-28       Impact factor: 3.411

Review 8.  Avian Mycobacteriosis: Still Existing Threat to Humans.

Authors:  Michal Slany; Vit Ulmann; Iva Slana
Journal:  Biomed Res Int       Date:  2016-07-31       Impact factor: 3.411

9.  Fatal Mycobacterium colombiense/cytomegalovirus coinfection associated with acquired immunodeficiency due to autoantibodies against interferon gamma: a case report.

Authors:  Sébastien Poulin; Claude Corbeil; Mélanie Nguyen; Anik St-Denis; Lise Côté; Françoise Le Deist; Alex Carignan
Journal:  BMC Infect Dis       Date:  2013-01-22       Impact factor: 3.090

10.  Prevalence of Non-Tuberculous Mycobacteria in Hospital Waters of Major Cities of Khuzestan Province, Iran.

Authors:  Azar Dokht Khosravi; Abdolrazagh Hashemi Shahraki; Mohammad Hashemzadeh; Rasa Sheini Mehrabzadeh; Ali Teimoori
Journal:  Front Cell Infect Microbiol       Date:  2016-04-13       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.